Aaron M. Cypess, M.D., Ph.D., M.M.Sc.


Translational Physiology Section, Diabetes, Endocrinology, and Obesity Branch


BG 10-CRC RM 6-3950



Research Topics

Research Goal

Brown adipose tissue (BAT) is an organ recently discovered to be functional in adults.  In mammals, BAT contributes to the heat generated during standard physiological non-shivering thermogenesis and may also play a role in protection from weight gain and insulin resistance in both rodents and humans.  At the cellular level, brown adipocytes regulate energy expenditure through their numerous, large mitochondria. In the inner mitochondrial membrane is the BAT-specific uncoupling protein 1 (UCP1), which when activated dissipates the intermembrane proton-motive force and generates heat instead of ATP.

The thermogenic capacity of BAT is impressive.  In a cold-acclimatized animal models, oxygen consumption by BAT is approximately twice the normal whole-body basal metabolic rate.  Until recently BAT was thought to be nonexistent and metabolically irrelevant in adult humans, in part because there were no methods to localize and quantify BAT mass and measure its activity.

Using a combination of molecular techniques and whole-body imaging, we have shown that BAT is present in adult humans in defined regions; more frequently found in women than men, and has an activity that correlates inversely with age and obesity, suggesting a potential role of brown adipose tissue in adult human metabolism.
Current translational research projects in the lab focus on brown and white adipose tissue function, energy balance, clinical physiology, and imaging in collaboration with multiple groups within the Intramural Research Program and Harvard Medical School.

Current Research

  1. Integrative physiology: we are conducting studies in both rodents and humans to understand BAT and WAT function and teleology from the molecular and cellular through the epidemiological levels.
  2. Noninvasive imaging: new technologies are being developed, including PET/CT, MRI, infrared, and ultrasound, to quantify BAT mass and activity as a way of understanding its structure and function.
  3. Therapeutics: physiological (exposure to mild cold) and pharmacological (activators of the β3-adrenergic receptor) interventions are being evaluated to identify which ones increase BAT energy expenditure and have the potential for use as treatments for obesity and diabetes.

Applying our Research

Obesity develops when energy intake exceeds energy expenditure.  This disruption of energy balance develops from a combination of increased drive to take in food and a decrease in energy expenditure.  In the classical view, adipose tissue itself was considered as a passive recipient, acting as a storage depot for the excess calories, rather than an active component of disease.

Over the past two decades, this view of obesity has changed dramatically with the recognition that adipose tissue is a metabolically and hormonally active tissue, releasing free fatty acids and producing a number of hormones or adipokines acting on other tissues, including the brain, liver, and muscle to play an important role in control of food intake, energy balance, and insulin sensitivity.  Moreover, adipose tissue itself is heterogeneous at multiple levels.  Increased intra-abdominal fat is associated with a high risk of metabolic disease, whereas increased subcutaneous fat in the thighs and hips exerts little or no risk of metabolic disease.

Recent evidence suggests that this difference in disease risk is, at least in part, due to intrinsic differences in adipocytes in the different depots, which may be developmental in origin.  In addition, it is known that not all fat is involved in energy storage. Rather, there are at least two clearly distinguishable forms of fat: white adipose tissue (WAT), which stores energy, and brown adipose tissue (BAT), which burns energy for thermogenesis.

The most recent strategic plan of the NIDDK states that we must “Determine whether human brown fat plays a major role in energy balance, and explore pharmacologic or environmental (temperature) approaches to manipulate brown fat activity to uncouple excess nutrient intake from energy storage in white fat tissue.”  It is our hope that our research effots will contribute specifically toward achieving this goal.

Need for Further Study

BAT may contribute to three different facets of human physiology - energy balance, fuel utilization, and the regulation of metabolism.  Answering the following three questions is the ultimate goal of our research:

  • To what extent does adult human BAT contribute to increased energy expenditure?
  • What is the intracellular response of human brown adipocytes to adrenergic stimulation, and how could this impact whole-body glucose and triglyceride metabolism?
  • How does activated human BAT interact with other tissues as an endorince organ?


  • Assistant Professor of Medicine, Harvard Medical School, 2010-2014
  • Assistant Investigator and Staff Physician, Joslin Diabetes Center, 2010-2014
  • Beth Israel Deaconess Medical Center, Staff Physician, 2006-2014
  • M.M.Sc., Harvard Medical School, 2008
  • M.D., Cornell Medical College, 2000
  • Ph.D., Rockefeller University, 1999
  • A.B., Princeton University, 1992

Selected Publications

  1. Baskin AS, Linderman JD, Brychta RJ, McGehee S, Anflick-Chames E, Cero C, Johnson JW, O'Mara AE, Fletcher LA, Leitner BP, Duckworth CJ, Huang S, Cai H, Garraffo HM, Millo CM, Dieckmann W, Tolstikov V, Chen EY, Gao F, Narain NR, Kiebish MA, Walter PJ, Herscovitch P, Chen KY, Cypess AM. Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist. Diabetes. 2018.

  2. Leitner BP, Weiner LS, Desir M, Kahn PA, Selen DJ, Tsang C, Kolodny GM, Cypess AM. Kinetics of human brown adipose tissue activation and deactivation. Int J Obes (Lond). 2018.

  3. Lynes MD, Leiria LO, Lundh M, Bartelt A, Shamsi F, Huang TL, Takahashi H, Hirshman MF, Schlein C, Lee A, Baer LA, May FJ, Gao F, Narain NR, Chen EY, Kiebish MA, Cypess AM, Blüher M, Goodyear LJ, Hotamisligil GS, Stanford KI, Tseng YH. Corrigendum: The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med. 2017;23(11):1384.

  4. Leitner BP, Huang S, Brychta RJ, Duckworth CJ, Baskin AS, McGehee S, Tal I, Dieckmann W, Gupta G, Kolodny GM, Pacak K, Herscovitch P, Cypess AM, Chen KY. Mapping of human brown adipose tissue in lean and obese young men. Proc Natl Acad Sci U S A. 2017;114(32):8649-8654.

  5. Chen KY, Cypess AM, Laughlin MR, Haft CR, Hu HH, Bredella MA, Enerbäck S, Kinahan PE, Lichtenbelt Wv, Lin FI, Sunderland JJ, Virtanen KA, Wahl RL. Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans. Cell Metab. 2016;24(2):210-22.

This page was last updated on July 16th, 2015